novo nordisk oral semaglutide brand name wins EU approval for Wegovy weight-loss pill Denmark-based #NovoNordisk, makers of popular

In August 2025 , the FDA approved Wegovy for another use: to treat a type of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH) in adults who have moderate to advanced liver scarring (fibrosis) but do not have permanent liver damage (cirrhosis)

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

So everyone should expect to have some swelling in their lips if they are injected in that area

Regulation of adipokine production in human adipose tissue by propionic acid